Press "Enter" to skip to content

Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket

Gainers

  • PaxMedica, Inc. PXMD shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.
  • Secoo Holding Limited SECO shares rose 29.6% to $0.35 in pre-market trading after dropping 7% on Thursday.
  • IVERIC bio, Inc. ISEE rose 20.9% to $20.84 in pre-market trading. Iveric Bio said that the FDA has granted breakthrough therapy designation for Avacincaptad Pegol for geographic atrophy.
  • StoneCo Ltd. STNE rose 20% to $11.84 in pre-market trading after the company reported Q3 results.
  • Ross Stores, Inc. ROST rose 16.6% to $114.20 in pre-market trading after the company reported better-than-expected Q3 results and issued strong earnings guidance.
  • Quhuo Limited QH rose 15.6% to $1.92 in pre-market trading. Quhuo recently reported better-than-expected H1 results.
  • Scopus BioPharma Inc. SCPS shares jumped 11.3% to $0.2710 in pre-market trading after dropping 5% on Thursday.
  • Golden Sun Education Group Limited GSUN rose 9.5% to $2.53 in pre-market trading after dropping 46% on Thursday.
  • Provention Bio, Inc. PRVB rose 9.1% to $8.99 in pre-market trading. Provention said on Thursday the U.S. Food and Drug Administration has given its nod for the use of TZIELD (teplizumab-mzwb) in those aged eight years and older — the first treatment targeted at delaying the onset of insulin-dependent type 1 diabetes.
  • Palo Alto Networks, Inc. PANW rose 8.6% to $170.00 in pre-market trading after the company reported better-than-expected results for its second quarter and issued strong FY23 earnings guidance. The company also announced plans to acquire Cider Security for approximately $195 million.
  • Biora Therapeutics, Inc. BIOR rose 7.4% to $0.2470 in pre-market trading after dropping 8% on Thursday. Biora Therapeutics recently posted a Q3 loss of $0.08 per share.
  • The Gap, Inc. GPS rose 7.2% to $13.63 in pre-market trading after the company reported better-than-expected Q3 sales results.
  • AppHarvest, Inc. APPH rose 7.1% to $1.36 in pre-market trading. AppHarvest recently reported worse-than-expected Q3 sales results.
  • Virax Biolabs Group Limited VRAX rose 5.7% to $1.49 in pre-market trading. Virax Biolabs recently named Richard Pallin as Vice President of In Vitro Diagnostic Sales.
  • Applied Materials, Inc. AMAT rose 3.8% to $108.37 in pre-market trading following upbeat quarterly results.

 

Don’t forget to check out our premarket coverage here .



Losers

  • Scilex Holding Company SCLX shares fell 28% to $6.72 in pre-market trading after gaining over 6% on Thursday.
  • G1 Therapeutics, Inc. GTHX fell 24.4% to $6.46 in pre-market trading after the company reported pricing of $50.05 million public offering of 7.7 million shares of common stock at a price of $6.50 per share.
  • BIMI International Medical, Inc. BIMI shares fell 17.2% to $0.21 in pre-market trading.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd. BHAT shares fell 12.1% to $0.6202 in pre-market trading.
  • Farfetch Limited FTCH fell 11.3% to $8.11 in pre-market trading after the company reported worse-than-expected Q3 revenues. Gross merchandise value decreased 4.9% year over year.
  • Tian Ruixiang Holdings Ltd TIRX fell 10.3% to $2.34 in pre-market trading after dropping 12% on Thursday.
  • Cuentas Inc. CUEN fell 9.1% to $0.2910 in pre-market trading after jumping 28% on Thursday.
  • Smart for Life, Inc. SMFL shares fell 9.1% to $0.40 in pre-market trading. Smart for Life recently posted Q3 sales of $5.40 million.
  • The Very Good Food Company Inc. VGFC fell 8.1% to $0.0715 in pre-market trading after gaining over 6% on Thursday.
  • Ensysce Biosciences, Inc. ENSC fell 6.7% to $2.37 in pre-market trading after dropping 9% on Thursday.
  • Zhihu Inc. ZH fell 6.6% to $1.27 in pre-market trading. Zhihu is expected to report Q3 financial results on November 30, 2022.

This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published.